# NeuroPace (NPCE) — News

NPCE · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/npce/news

## Recent headlines

- [Orsl unit wins BPCL EPCOM pact for CBG plant in Hubli](https://www.ainvest.com/news/orsl-unit-wins-bpcl-epcom-pact-cbg-plant-hubli-2610) — AInvest Wire, Oct 12, 2026
  Oriana Power Limited has secured a contract to provide engineering, procurement, and construction (EPC) services for a compressed biogas (CBG) plant in Hubli, India. The project is part of a broader national initiative to expand domestic CBG production and reduce reliance on imported natural gas.…
- [Neuropace, Inc.: KeyBanc initiates coverage with overweight rating and target price $18](https://www.ainvest.com/news/neuropace-keybanc-initiates-coverage-overweight-rating-target-price-18-2609) — AInvest Wire, Sep 18, 2026
  KeyBanc Capital Markets has initiated coverage of NeuroPace, Inc. (NASDAQ: NPCE) with an Overweight rating and a $18 price target, according to a research note from analyst Brett Fishbin . The analyst highlighted the company’s differentiated approach to treating drug-resistant epilepsy, noting its…
- [NeuroPace drops 16% postmarket on negative FDA guidance](https://www.ainvest.com/news/neuropace-drops-16-postmarket-negative-fda-guidance-2607) — AInvest Wire, Jul 28, 2026
- [NeuroPace - to submit submission issue request and amend PMA supplement](https://www.ainvest.com/news/neuropace-submit-submission-issue-request-amend-pma-supplement-2607) — AInvest Wire, Jul 28, 2026
- [NeuroPace Inc: Mizuho initiates coverage with outperform rating; target price $22](https://www.ainvest.com/news/neuropace-mizuho-initiates-coverage-outperform-rating-target-price-22-2607) — AInvest Wire, Jul 23, 2026
  Mizuho Securities has initiated coverage of NeuroPace Inc (NASDAQ: NPCE) with an "outperform" rating and a target price of $22 per share, according to a recent report[1]. The firm cited the company’s progress in advancing its neurotechnology platform and expanding its therapeutic applications as…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).